Stock NANO NANOBIOTIX
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Nanobiotix

Equities

NANO

FR0011341205

Real-time Euronext Paris
Other stock markets
 06:49:40 2024-05-21 am EDT 		5-day change 1st Jan Change
6.44 EUR -1.98% Intraday chart for Nanobiotix -4.73% -3.01%
May. 14 Nanobiotix to Proceed to Phase 2 Trial of Lung Cancer Treatment MT
May. 14 Nanobiotix Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating Nbtxr3 for Patients with Stage Three Lung Cancer CI
438ac655.J4llZUh16xOSYQ1WwU8FR8CpP568bscztzpdzXKcS08.Rc48Pwsf2WmhJmZnkCt9BbHIVvTEO6lR3kMrqRz6OwJVxDMxCy-5JNFWeg~ee920cf422fb8f84cdcca0d3795f17b5
  1. Stock Market
  2. Equities
  3. NANO Stock
  4. Charts Nanobiotix
  5. News Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW